Menu
Antibiotic Stewardship for Drug resistant Tuberculosis.

Padayatchi N, Mahomed S, Loveday M, Naidoo K.
Expert Opinion On Pharmacotherapy 2016 August. DOI: 10.1080/14656566.2016.1225724

Read publication
Metabolic syndrome after HIV acquisition in South African women.

Sobieszczyk ME, Werner L, Mlisana K, Naicker N, Feinstein A, Gray CM, Masson L, Passmore J-AS, Williamson C, Abdool Karim Q, Abdool Karim SS, Garrett NG.
JAIDS 2016 July. DOI: 10.1097/QAI.0000000000001123

Read publication
Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.

Padayatchi N, Naidu N, Yende-Zuma N, O’Donnell MR, Naidoo K, Augustine S, Zumla A, Loveday M.
JAIDS 2016 September; 73(1):e1-7. doi: 10.1097/QAI.0000000000001110.

Read publication
CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles.

Koofhethile CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, Ismail N, Mncube Z, Mkhize I, Van der Stok M, Yende-Zuma N, Walker BD, Goulder PJ, Ndung'u T.
Journal of Virology 2016 July; 90(15):6818-31. doi: 10.1128/JVI.00276-16.

Read publication
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.

Archary D, Seaton KE, Passmore JS, Werner L, Deal A, Dunphy LI, Arnold KB, Yates NL, Lauffenburger DA, Bergin P, LiebenbergLI, Samsunder N, Mureithi MW, Altfeld M, Garrett N, Abdool Karim Q, Abdool Karim SS, Morris L, and Tomaras GD.
Mucosal Immunology 2016 May; 9(3): 821–833. doi:10.1038/mi.2015.145.

Read publication
A qualitative evaluation of the acceptability of an interactive voice response system to enhance adherence to isoniazid preventive therapy among people living with HIV in Ethiopia.

Daftary A, Hirsch-Moverman Y, Kassie GM, Melaku Z, Gadisa T, Saito S, Howard AA.
AIDS and Behavior 2016 May 24. Doi:10.1007/s10461-016-1432-8

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.